Excision Combined with Ocular Surface Reconstruction Followed by Topical Chemotherapy for Ocular Surface Squamous Neoplasia

Overview

Journal Jpn J Ophthalmol

Specialty Ophthalmology

Date 2024 Oct 2

PMID 39356385

Authors

Hiroko Nakai

Kosuke Ueda

Koji Kitazawa

Hideki Fukuoka

Tsutomu Inatomi

Norihiko Yokoi

Shigeru Kinoshita

Go Horiguchi

Satoshi Teramukai

Chie Sotozono

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the visual prognosis of ocular surface squamous neoplasia (OSSN) after tumor resection and ocular surface reconstruction, and clarify factors that influence recurrence.

Study Design: Retrospective cohort study.

Methods: Medical records of all patients who underwent surgical treatment for OSSN at our hospital between January 1996 and December 2019 were reviewed. Tumor size/location, histological classification, surgical procedure, intraoperative mitomycin-C use, and postoperative topical 5-fluorouracil (5-FU) administration were examined, and pre and postoperative visual acuity (VA) were compared to elucidate factors that influence disease recurrence.

Results: Tumor excision was performed in 70 eyes of 70 cases (43 men, 27 women; average age: 71.6 ± 12.6 years) with dysplasia (8 eyes), carcinoma in situ (26 eyes), and invasive squamous cell carcinoma (36 eyes). Tumors were found in the limbus (N = 59 eyes), palpebral conjunctiva (N = 8 eyes), and from the bulbar to palpebral conjunctiva (N = 3 eyes). Surgical procedures performed were limbal transplantation/keratoepithelioplasty (N = 29 eyes), cultivated oral mucosal epithelial transplantation (N = 3 eyes), and auto-conjunctival epithelium transplantation (N = 2 eyes). Ocular surface was reconstructed using amniotic membrane, donor cornea, or cultivated epithelial sheet. The mean follow-up was 38.6 ± 38.6 months (range, 2 months to 13.8 years). VA postoperatively improved in 25 (61.0%) cases. Recurrence occurred in 19 (27.1%) cases at from 2 to 50 months (median: 12.5 months) postoperative. Uni- and multivariate analyses revealed that presurgical tumor size and postoperative administration of 5-FU were significantly related to recurrence.

Conclusion: Combined surgical excision and postoperative topical 5-FU administration effectively prevented OSSN recurrence, and ocular surface reconstruction contributed to improvement of VA.

References

Yamamoto N, Ohmura T, Suzuki H, Shirasawa H . Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmology. 2002; 109(2):249-52. DOI: 10.1016/s0161-6420(01)00926-5. View

Ohara M, Sotozono C, Tsuchihashi Y, Kinoshita S . Ki-67 labeling index as a marker of malignancy in ocular surface neoplasms. Jpn J Ophthalmol. 2004; 48(6):524-9. DOI: 10.1007/s10384-004-0129-0. View

Yeatts R, Ford J, Stanton C, Reed J . Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 1995; 102(9):1338-44. DOI: 10.1016/s0161-6420(95)30866-4. View

Gupta A, Muecke J . Treatment of ocular surface squamous neoplasia with Mitomycin C. Br J Ophthalmol. 2010; 94(5):555-8. DOI: 10.1136/bjo.2009.168294. View

Midena E, Angeli C, Valenti M, De Belvis V, Boccato P . Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000; 84(3):268-72. PMC: 1723406. DOI: 10.1136/bjo.84.3.268. View

Shields C, Demirci H, Karatza E, Shields J . Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004; 111(9):1747-54. DOI: 10.1016/j.ophtha.2004.02.013. View

Koizumi N, Nishida K, Adachi W, Tei M, Honma Y, Dota A . Detection of herpes simplex virus DNA in atypical epithelial keratitis using polymerase chain reaction. Br J Ophthalmol. 1999; 83(8):957-60. PMC: 1723153. DOI: 10.1136/bjo.83.8.957. View

Kemp E, Harnett A, Chatterjee S . Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Br J Ophthalmol. 2002; 86(1):31-4. PMC: 1770962. DOI: 10.1136/bjo.86.1.31. View

Rozenman Y, Frucht-Pery J . Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C. Cornea. 2000; 19(1):1-6. DOI: 10.1097/00003226-200001000-00001. View

10.

Kaliki S, Mohammad F, Tahiliani P, Sangwan V . Concomitant Simple Limbal Epithelial Transplantation After Surgical Excision of Ocular Surface Squamous Neoplasia. Am J Ophthalmol. 2016; 174:68-75. DOI: 10.1016/j.ajo.2016.10.021. View

11.

Frucht-Pery J, Sugar J, Baum J, Sutphin J, Peer J, SAVIR H . Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 1997; 104(12):2085-93. DOI: 10.1016/s0161-6420(97)30055-4. View

12.

Erie J, Campbell R, Liesegang T . Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986; 93(2):176-83. DOI: 10.1016/s0161-6420(86)33764-3. View

13.

Koizumi N, Inatomi T, Sotozono C, Fullwood N, Quantock A, Kinoshita S . Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000; 20(3):173-7. View

14.

Gichuhi S, Macharia E, Kabiru J, Zindamoyen A, Rono H, Ollando E . Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2016; 4(6):e378-85. PMC: 5081398. DOI: 10.1016/S2214-109X(16)30052-3. View

15.

Perez-Garcia P, Burgos-Blasco B, Gomez-Calleja V, Vidal-Villegas B, Mendez-Fernandez R, Gegundez-Fernandez J . Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b. J Oncol Pharm Pract. 2022; 29(4):975-979. DOI: 10.1177/10781552221125763. View

16.

Schechter B, Schrier A, Nagler R, Smith E, Velasquez G . Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea. 2002; 21(1):6-11. DOI: 10.1097/00003226-200201000-00003. View

17.

Shields C, Paulose S, Yaghy A, Dalvin L, Constantinescu A, Lally S . Ocular Surface Squamous Neoplasia Managed With Primary Interferon α2b: A Comparative Analysis of 212 Tumors in Smokers Versus Nonsmokers. Cornea. 2020; 40(11):1387-1394. DOI: 10.1097/ICO.0000000000002615. View

18.

Kinoshita S, Kiorpes T, Friend J, THOFT R . Limbal epithelium in ocular surface wound healing. Invest Ophthalmol Vis Sci. 1982; 23(1):73-80. View

19.

Yeatts R, Engelbrecht N, Curry C, Ford J, Walter K . 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000; 107(12):2190-5. DOI: 10.1016/s0161-6420(00)00389-4. View

20.

Hllhumer R, Williams S, Michelow P . Ocular surface squamous neoplasia: management and outcomes. Eye (Lond). 2021; 35(6):1562-1573. PMC: 8169825. DOI: 10.1038/s41433-021-01422-3. View